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ABSTRACT 
 
Bovine mastitis is the most prevalent disease in the production of dairy cattle worldwide.  
 
The present study aimed to characterize the main etiological agents of mastitis and the 
corresponding susceptibility patterns in 700 milk samples submitted to the Azorean regional 
laboratory in 2013. A questionnaire was also performed to determine the relationship of the 
isolated agents with different types of management practices and features of the dairy farms  
that produced the analyzed milk samples. 
Environmental agents were the ones more frequently isolated namely Escherichia coli and 
Streptococcus uberis. Contagious agents were less frequently isolated, of which 
Staphylococcus aureus was the most frequently isolated. Amoxicilin plus clavulanic acid was 
the antibiotic combination to which a larger number of agents was susceptible to. 
Some management practices were significantly associated with the isolation of certain bacteria 
in mastitic milk samples, namely the extension of the dry periods and the use of internal teat 
sealant. 
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1. INTRODUCTION 
 
Bovine mastitis is the most prevalent disease found in the production of dairy cattle worldwide 
and accounts for several negative effects (Seegers et al., 2003). 
This disease is characterized by an inflammation of the mammary gland, caused mostly by 
bacteria but might also have fungi and algae as causative agents (Spanamberg et al., 2009; 
Peixoto et al., 2010). Udder pathogens have been divided in environmental and contagious 
organisms based in the transfer of organisms from the reservoirs to the teats between milkings 
or in the transmission from the carrier cow or quarter to the teats of non-infected cows/quarters 
during the milking process, respectively (Blowey & Edmondson, 2010).. 
Milk yield and composition may be altered only in the short time in less severe mastitis cases. 
However, in more severe cases the changes can remain in the long-term. These effects may 
even occur in the following lactation (Seegers et al., 2003). 
In Portugal, the only available estimation of the costs of mastitis in dairies, refer to the Northern 
mainland region of Entre-Douro e Minho and are about 249€/mastitis/year. The reasons that 
mostly contribute to these losses are mortality and premature culling (Aires, 2010). 
Due to occurrence of mastitis, there is an increase of the somatic cell count in the milk. A 
healthy udder and consequently a low level of somatic cells, avoids pecuniary penalization of  
the producers and, simultaneously, benefits the consumer and the dairy industry since both will 
have a product of greater quality (Blowey & Edmondson, 2010). 
Currently, antibiotic (AB) therapy remains an important component of herd health programs to 
control intramammary (IMM) infections in dairy cows (Guérin-Faublée et al., 2002). The 
knowledge of the type of agent, as well as the susceptibility profile to several AB agents, can 
improve the success rates of the IMM infection treatment as well as contribute to the reduction 
of bacterial resistance (Silva et al., 2004). 
It is well established that the indiscriminate use of AB agents to treat mastitis or other type of 
infections may produce an increased level of resistance of many bacteria (Silva et al., 2004). AB 
resistances have become an increasing problem in human and veterinary medicine, which can 
embody serious implications in terms of public health, since it may cause failures in treatments, 
death and prolonged illness, as well as increased costs associated with the treatment (Rangel & 
Marin, 2009). 
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The agricultural sector in the Azorean archipelago accounts for 10% of the region’s economy, of 
which 54% refers to milk production. About 80% of the milk produced in Azores is exported and 
represents 27% of the total Portuguese dairy production (Ponte, 2009). In the year of 2013, in 
the Azorean archipelago, 536,074,200 liters of milk were produced, of which 65.1% were 
produced in the island of São Miguel (SREA, 2004). 
The present study was drawn in view of the significance of the dairy farms to the local and 
national economy, and the absence of similar studies applied to this important milk-producing 
region. The main objectives were to characterize the main etiological agents identified in the 
laboratory submitted milk samples, as well as to determine their relationship with different types 
of management practices and the features of the dairy farms of the Azorean island of São 
Miguel. Furthermore, AB susceptibility patterns of major mastitis pathogens isolated were 
assessed, based on the laboratory records of one of the local dairy farmers association, 
throughout the previous year of 2013. 
 
 
2. MATERIALS AND METHODS 
 
 
 
2.1. Characterization of the region and farms 
The farms from which the animals originated were located in the island of São Miguel, also 
known as the “green island”. This is the largest island of the Portuguese archipelago of Azores 
(composed by nine islands), situated in the Atlantic Ocean with their respective coordinates 
37°47’N and 25°30’O. S. Miguel is located in the Oriental group of the archipelago and has an 
area of about 746,82km
2
. The climate in this region typically features a mild temperature with  a 
high humidity, usually overcast with a regularly distributed rainfall throughout the year (Sousa, 
2007). 
Pastures occupy about 90% of the agricultural area in São Miguel. Terrain has steep slopes that 
sometimes hamper the access to farms and difficult agricultural work. The soils are very rich in 
potassium while very deficient in phosphorus, and, in a smaller scale, in calcium and 
magnesium. Regarding the micronutrients, studies reveal scarcity in selenium, zinc, copper, 
cobalt and iodine (Sousa, 2007). 
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The feeding regime of dairy cows is based primarily in pasture grazing. Currently, in São   
Miguel, most animals are not housed and are rather in pasture the whole year, which means 
that they are exposed to adverse weather conditions. Nevertheless, a small number of farms 
have started to build covered collective or individual areas with sand or straw. Mobile outdoor 
milking equipment is the most widely used. It is during milking that most farmers supply 
concentrate feeds. 
The predominant breed on all herds is Holstein-Friesian although some producers are 
incorporating the Jersey breed in their farms, as they are animals that are better adapted to high 
and sloping pastures due to their low weight and height (Sousa, 2007). 
 
 
2.2. Sample and data collection 
 
Data was collected from one of the two existing farmers’ associations on the island of São 
Miguel, the Associação de Jovens Agricultores Micaelenses (AJAM). The AJAM gathers almost 
half of the dairy farms of the island, providing technical support and veterinary assistance. 
However, the laboratory of the AJAM serves other farms, beyond the ones registered in the 
association. 
Laboratory data were collected retrospectively, in January 2014, and accounted for results of all 
samples submitted to the AJAM laboratory throughout the year 2013, by 133 different farms. 
Data records on the laboratory’s database for each of the total 700 individual samples included 
individual animal identification, farm identification and farm location, as well as microorganism 
identification based on culture and their corresponding susceptibility for the following AB agents: 
marbofloxacin (5µg), danofloxacin (5µg), cefoperazone (75µg), cefquinome (30µg), kanamycin 
(30µg), amoxicillin plus clavulanic acid (25µg), cefazolin (30µg), spiramycin (100µg), lincomycin 
(75µg), gentamicin (120µg), ampicillin (10µg), trimethoprim sulfa (1,25µg), pirlimycin (2µg) and 
tylosin (30µg). An disk additionally employed comprised three AB agents, penethamate 
hydroiodide, dihydrostreptomycin sulphate and framycetin sulphate. Records were not obtained 
for resistance patterns. 
In addition to the laboratory records, a questionnaire was held concerning the characteristics 
and management practices of n=105 holdings. Only AJAM-associated farms were considered 
given that the questionnaire was performed during the scheduled veterinary support visits to the 
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farms between September 5
th 
and December 11
th 
of 2013. Previously informed producers 
consented for both collection and publication of data. The total number of cows of all enrolled 
herds was approximately 6,000 and the average farm size was about 170 animals, being the 
minimum herd size 23 animals and the maximum 320. The questionnaire was aimed at various 
aspects, in particular: feeding regime, existence of cowshed and cow maternity, number of 
milking cows, duration of dry periods and use of internal teat sealants and IMM AB at drying off. 
Particular aspects of milking hygiene were also abridged, such as the use of gloves during 
milking procedures, pre- and post-dipping with teat disinfectants, type of milking machine and 
criteria for milking cows with mastitis. 
 
 
2.3. Statistical analysis 
 
Available data were submitted to several exploratory analyzes through the Excel
TM 
and SAS
TM 
(Statistical package) programs. Frequencies were determined for factors studied through the 
program Proc Freq SAS (SAS Institute, 2004). 
The probability of occurrence of the various environmental and contagious agents was analyzed 
by logistic regression, with the Proc Logistic (SAS). The following factors were also evaluated: 
region, type of exploration, dry periods, teat sealant, teat dipping, criteria for milking cows with 
mastitis, type of milking machine, period of the year and number of animals. 
Statistical significance was defined previously for test results with a p-value <0.01 and <0.05, for 
the different tests. 
The calculation of other percentages was performed with Microsoft Excel 2010 software. 
 
 
 
3. RESULTS AND DISCUSSION 
 
 
 
3.1. Mastitis pathogens 
 
Overall, a single agent was isolated in 65% (455/700) of the analyzed samples, whereas in 25% 
(176/700) two agents were isolated and in 1% (7/700) three agents. No growth was observed in 
about 9% (62/700) of the milk samples (Figure 1). 
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Figure 1. Isolated agents in analyzed samples, (1) – Samples with single agent isolates; (2) – 
Samples with 2 agents isolated; (3) – Samples with 3 agents isolated; (4) – Samples with no 
growth. 
 
 
Of all agents isolated (n=826) through culture, the majority corresponded to environmental 
agents (83%; n=689) and, nearly 17% (n=137) to contagious agents. The main reservoir of 
mastitis environmental agents is the environment of the herds and the exposure of healthy 
quarters to these agents can occur at any time during the life of a cow. On the other hand, for 
contagious mastitis, the first reservoir is the cow itself, and exposure of uninfected mammary 
quarters to contagious agents is restricted to the milking process (Zadocks et al., 2001). As 
mentioned before, most cows in the herds of São Miguel are at pasture throughout the year, 
where they are exposed to environmental agents. An overcrowded pasture also contributes to a 
greater contamination by environmental agents (Blowey & Edmondson, 2010). 
Considering the environmental agents only (n=689; Figure 2), Escherichia coli (E. coli) 
corresponded to 30% (207/689) of isolates, whereas it corresponded to circa 25% (207/826) of 
the total positive samples. It should be noted, however, that the occurrence of this agent can be 
underestimated due to the false negatives resulting from the short duration of the infection, the 
fast immune response and its ensuing rapid elimination (Morn, 2009; Blowey & Edmondson, 
2010). The bacteria E. coli is ubiquitous, being the most prevalent agent in farms, since it is 
present in feces and can contaminate different materials, such as bedding  and  water. This 
agent causes mastitis when teats are exposed to fecal contaminated material. Thus prevalence 
(3) 
1% 
(4) 
9% 
(2) 
25% 
(1) 
65% 
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of E. coli in farms increases with poor hygiene or high animal density. Rainfall and  low 
frequency of pasture rotation can also influence the extent of exposure to E. coli (Morn, 2009; 
Rangel & Marin, 2009). These features are present in the herds of São Miguel, since most of 
the cows are at pasture and the climate presents regular rainfall throughout the year. 
Coagulase-negative staphylococci (CNS) were isolated in nearly 14% (95/689) of the total 
isolated environmental agents, corresponding to 11.5% (95/826) of the total positive samples. 
CNS comprises 9 species and 16 subspecies. These agents are usually found in teat skin, teat 
end and teat canal of animals (Thorberg et al., 2009; Blowey & Edmondson, 2010). 
 
 
 
Figure 2. Percentage distribution of isolated environmental agents (n=689) in the analyzed milk 
samples (CNS, Coagulase-negative Staphylococci). 
 
Streptococcus uberis (S. uberis) was isolated in 13.2% (91/689) of the total environmental 
agents’ isolates, corresponding to 11% (91/826) of the total positive samples. S. uberis is the 
most common causative agent of mastitis in modern dairy herds according to Zadocks et al. 
(2007), although only the 5
th 
most frequently isolated agent in the farms of São Miguel. The 
 
capacity of this agent to survive in the environment may be enhanced by the presence of 
hyaluronic acid capsule (Lopez-Benavides et al., 2007). Bedding with sand and straw is 
associated with high levels of S. uberis, as once contaminated with milk, urine or feces, will 
allow bacterial proliferation. However, it can also be found in the mouth, vulva, groin and axilla  
of cows. Furthermore, this agent can also affect cows in pasture, since it is present in feces. 
Nevertheless, its frequency of isolation is not comparable with the one of E.coli (Blowey & 
Edmondson, 2010). Zadocks (2007) refer that S. uberis can behave either as an environmental 
agent or as a contagious agent. Indeed, it has been observed in several farms that many 
E.coli 
30% Enterococus 
24% Streptococcus 
Non-agalactiae 
CNS 
17% 
14% 
S.uberis 
13% 
Others 
Streptococcus 
dysgalactiae 
1.5% 0.9% 
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animals within a herd had the same or closely related strain of S. uberis. This could be the  
result of a predominance of a determined strain in the environment or otherwise a contagious 
transmission. Rato et al. (2013) reported heterogeneity in pulsed-field gel electrophoresis 
(PFGE) patterns between S. uberis isolates of different farms; as, a patterns were specific in the 
same farm, a direct transmission of S. uberis among animals within the same farm can thus be 
suggested. 
The findings of the present study, referring to the herds of the São Miguel island, reinforce the 
need to prevent mammary infections namely by environmental agents like E. coli. Measures to 
prevent environmental mastitis include rotating pasture, avoiding overstocking, paying attention 
to hygiene around feeding areas, and creating maternities in order to avoid contamination at the 
time of parturition (Blowey & Edmondson, 2010). 
Regarding classical contagious agents (n=137), and as displayed in Figure 3, Staphylococcus 
aureus (S. aureus) corresponded to almost 60% (82/137) of the total isolated contagious agents 
and to nearly 10% (82/826) of the total positive samples. IMM infections by this agent are 
chronic and subclinical, with periods of clinical mastitis. When established, infection is extremely 
hard to eliminate. As the excretion of this agent is intermittent, a negative culture does not 
necessarily imply that the cow is free of S. aureus. Therefore, it is possible that the real 
occurrence of this agent is higher, taking into account the possibility of intermittent negative 
results during culture. These infections usually are spread from cow to cow at milking (Morn, 
2009; Blowey & Edmondson, 2010). 
Streptococcus agalactiae (S. agalactiae) was isolated in 22.6% (31/137) of the total isolated 
contagious agents, corresponding to 3.8% (31/826) of the total positive samples and is a major 
contagious pathogen. Despite an observed trend of decreasing occurrence, in the past few 
years, S. agalactiae remains a significant cause of mastitis in herds with  poor management 
(Merl et al., 2003). Blowey & Edmondson (2010) reported that the isolation of this agent is a 
good indicator of hygiene breaching during milking. 
Corynobacterium bovis was isolated in 15% (21/137) of the total isolated contagious agents, 
corresponding to 2.5% (21/826) of the total positive samples. This agent can be isolated from 
the teat canal (Blowey & Edmondson, 2010). Comparing two techniques of milk collection, 
Bexiga et al. (2010) reported that milk samples collected with a cannula surpassing the teat 
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canal decreased the isolation of Corynobacterium bovis when compared with milk samples 
collected with the standard technique, probably because the first technique avoids 
contamination of the milk samples with teat canal flora. 
Mycoplasma was the less frequently isolated agent. Considering the total isolated contagious 
agents, Mycoplasma was found in 2.2% (3/137), which corresponded to 0.4% (3/826) of the  
total positive samples. According to Pinho (2013), the prevalence of Mycoplasma in dairy herds 
of Northwestern Portugal was determined as not higher than 3%. 
 
Mycoplasma 
(2%) 
 
 
 
Figure 3. Percentage distribution of isolated contagious agents (n=137). 
 
 
 
3.2. Antibiotic susceptibility patterns 
 
AB susceptibility was determined in 842 isolates as summed up in Table 1. Amoxicillin plus 
clavulanic acid (aminopenicillins) was the AB to which a larger number of agents was sensible 
to, specifically 15.9% (134/842). Considering E. coli isolates only, 28.6% (73/255) were 
susceptible to marbofloxacin, 14% (36/255) to danofloxacin (which represents a sensitivity of 
42.6% of strains to the tested fluoroquinolones), and almost 12% (30/255) were susceptible to 
kanamycin (of the aminoglycoside group). Previously, Saini et al. (2012) reported the resistance 
of this agent to kanamycin, ampicillin, streptomycin and tetracycline. Although in the present 
study nearly 12% of the E. coli isolates were susceptible to kanamycin, it is not possible to 
assume that remaining isolates were resistant to this drug, as resistance patterns were not 
available. Rocha (2013) reported resistance of this bacteria to amoxicillin plus clavulanic acid in 
30% of herds evaluated in mainland Portugal. In the present study,susceptibility of the agents  to 
Streptococcus 
agalactiae 
(23%) 
Corynobacteriu 
m bovis 
(15%) 
Staphycococcus 
aureus 
(60%) 
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this combination of AB was only 8.6%, but again patterns of resistance were not available to 
allow comparison with mainland. 
In relation to S. uberis isolates, 19.6% (22/112) were susceptible to kanamycin, 18.8% (21/112) 
to amoxicillin plus clavulanic acid and approximately 11.6% (13/112) to spiramycin, a macrolide. 
Rocha (2013) reported resistance of S. uberis to gentamicin (71%) and cloxacillin (22.1%) in 
herds from the mainland of Portugal. In the routine antibiograms performed in the laboratory of 
AJAM, cloxacillin is not included. Moreover, sensibility of S. uberis to gentamicin in the São 
Miguel Island was only 1%. According to Blowey & Edmonson (2010), the low efficacy treatment 
of S. uberis and long refractory period in the udder, may be due to factors such as resistance to 
phagocytosis, maintenance inside the cells where many ABs cannot act, permanency in the 
mammary lymph node, kept as a reservoir of infection. 
The results obtained for S. aureus showed that 24.6% (16/65) of isolates were susceptible to 
amoxicillin plus clavulanic acid, 20% (13/65) to cefoperazona (a third-generation cephalosporin) 
and 16.9% (11/65) to tylosin (macrolide). Rocha (2013) refer an increased resistance to the AB 
combination of amoxicillin plus clavulanic acid from 2004 (0.7%) to 2012 (26.6%), in dairy cattle 
from the mainland of Portugal. Once more, as only the susceptibility patterns were available for 
the herds of São Miguel, comparison of resistance patterns is not possible. Due to the 
production of enzymes and endotoxins by S. aureus strains, damage is caused in mammary 
cells which results in fibrosis and abscess formation. Some strains can also form biofilms in the 
udder. Consequently, IMM infections by S. aureus rarely resolve spontaneously and are difficult 
to treat with ABs (Morn, 2009; Melchior, 2009). Nevertheless, in a first-time infection the cure 
rates may be improved (Blowey & Edmondson, 2010). Through Polymerase Chain Reaction 
(PCR) it is possible to detect the presence of AB resistance genes or presence of genes that 
have been correlated with biofilm formation in S. aureus. The presence of these genes 
decreases the treatment success (Melchior et al., 2009). 
S. agalactiae has a good response to antibiotic therapy and almost all antibiotics are effective 
according to Blowey & Edmondson (2010). In this study, 21.6% (11/51) of S. agalactiae isolates 
were sensible to amoxicilin plus clavulanic acid and spiramycin. Previously, Rocha (2013) 
reported the lowest AB resistance proportions (0 to 11.4%) of S. agalactiae in comparison with 
the remaining tested bacterial isolates. 
  
 
Table 1. Number of bacterial isolates susceptible to each tested AB. 
 
 E. coli 
(n=255) 
S. Non-agalactiae 
(n=121) 
S. uberis 
(n=112) 
Enterococcus 
(n=168) 
S. aureus 
(n=65) 
CNS 
(n=43) 
C. bovis 
(n=1) 
S. agalactiae 
(n=51) 
S. dysgalactiae 
(n=10) 
Others 
(n=15) 
Total 
(n=842) 
 
Marbofloxacin 
 
73 
 
5 
 
0 
 
6 
 
0 
 
2 
 
0 
 
0 
 
0 
 
2 
 
88 
 
Danofloxacin 
 
36 
 
4 
 
0 
 
1 
 
0 
 
3 
 
0 
 
0 
 
0 
 
0 
 
44 
 
Cefoperazone 
 
28 
 
12 
 
5 
 
29 
 
13 
 
11 
 
1 
 
3 
 
0 
 
4 
 
106 
 
Cefquinome 
 
19 
 
2 
 
1 
 
1 
 
4 
 
3 
 
0 
 
0 
 
0 
 
0 
 
30 
 
Kanamycin 
 
30 
 
11 
 
22 
 
0 
 
3 
 
1 
 
0 
 
5 
 
1 
 
1 
 
75 
 
Amoxicillin + clavulanic acid 
 
22 
 
20 
 
21 
 
26 
 
16 
 
9 
 
0 
 
11 
 
3 
 
9 
 
134 
 
Cefazolin 
 
1 
 
3 
 
12 
 
0 
 
2 
 
0 
 
0 
 
2 
 
3 
 
3 
 
23 
 
Spiramycin 
 
7 
 
11 
 
13 
 
21 
 
7 
 
3 
 
0 
 
11 
 
1 
 
2 
 
76 
 
Lincomycin 
 
18 
 
24 
 
9 
 
50 
 
4 
 
3 
 
0 
 
10 
 
1 
 
3 
 
121 
 
Gentamicin 
 
0 
 
0 
 
1 
 
0 
 
1 
 
0 
 
0 
 
0 
 
0 
 
0 
 
2 
 
Ampicillin 
 
4 
 
10 
 
10 
 
7 
 
1 
 
4 
 
0 
 
2 
 
0 
 
0 
 
38 
 
Trimethoprim 
 
6 
 
5 
 
3 
 
8 
 
1 
 
2 
 
0 
 
2 
 
1 
 
1 
 
28 
 
Disk with 3 AB * 
 
11 
 
12 
 
13 
 
19 
 
2 
 
2 
 
0 
 
4 
 
0 
 
0 
 
63 
 
Pirlimycin 
 
0 
 
0 
 
1 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
1 
 
Tylosin 
 
0 
 
0 
 
1 
 
0 
 
11 
 
0 
 
0 
 
1 
 
0 
 
0 
 
13 
(AB, Antibiotic; CNS, Coagulase-negative Staphylococci; S. Non-agalactiae, Streptococcus non-agalactiae; C. bovis, Corynobacterium bovis; S. dysgalactiae, Streptococcus dysgalactiae; *,  comprising  penethamate 
hydroiodide, dihydrostreptomycin sulphate and framycetin sulphate;) 
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The purpose of the treatment of mastitis is to guarantee that effective AB concentrations are 
reached at the site of infection. The most frequently used route of administration for treatment of 
mastitis is IMM, as a large concentration of ABs in the mammary gland is reached because the 
AB is administered directly into the site of infection. With parenteral administration, it is difficult  
to achieve and maintain a concentration in milk or tissue. Systemic treatment is recommended 
in some situations, like in clinical mastitis due to S. aureus (in combination with IMM treatment) 
and severe coliform mastitis (Pyorola, 2006). Some classes of ABs are not available in 
preparation for IMM administration in the Portuguese market, as is the case of quinolones and 
macrolides. In the present study, the overall AB susceptibility of isolated bacteria to quinolones 
was nearly 16%. 
 
 
3.3. Relationship between udder pathogens, herd’s holding and management practices 
According to results of the questionnaire carried out in 105 holdings, some management 
procedures were significantly associated with the isolation of certain bacteria in mastitic milk 
samples. 
The use of internal teat sealants had a positive association with the milk samples tested positive 
for E.coli (p<0.05). According to such result, holdings that always use internal teat sealants  
have a higher probability to have E. coli mastitis, whereas, holdings that rarely use internal teat 
sealants have less probability to have this type of mastitis. This finding is in contrast with 
previous studies that reported significantly fewer IMM infection using teat sealants (Berry & 
Hillerton, 2002). This result can also be explained by the fact that teat sealant is being mostly 
used by farms that have greater mastitis problems. In addition, if aseptic techniques are not 
warranted during sealant installation, pathogens present around the teat, in the environment or  
in the disinfectants and utensils can reach the teat ends and the teat canal, promoting infection 
(Huscley et al., 2002). As such, in future studies it is necessary to ascertain in more detail this 
association. 
Additionally, the herd size had a statistically significant association with isolation of E. coli and 
Enterococcus (p<0.01). Regarding E. coli, the frequency of isolation increases as the number of 
animals in the herd increases, whereas for Enterococcus, the positivity of isolation decreases 
when the number of animals in the herd increases. Likewise, already previously, Rangel and 
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Marin (2009) reported that E. coli increases in farms featuring a greater animal density and 
larger herds might be in greater risk for pasture overcrowding. 
Milking order of mastitic cows also showed a statistically significant association with 
Enterococcus (p<0.05) isolation. Statistical analysis showed that farms where cows with mastitis 
were left to be milked last were less prone to test positive for Enterococcus. This is in 
accordance with the recommended measures for prevention and control of mastitis in dairy 
cows (as recently reviewed by Blowey and Edmondson, 2010). But given that Enterococcus is 
not a contagious agent it is surprising that this association has not occurred with contagious 
agents, as infections with contagious agents usually are spread from cow to cow at milking. 
Possible effects of dry period length were also investigated, since it is necessary, for normal cell 
turnover and regeneration between lactations. Thus average length variation can affect future 
production level and, eventually, udder health (Collier et al., 2012). Watters et al. (2008) refer 
that cows submitted to a dry period between 60 and 69 days produced more milk in the 
subsequent lactation than those given a dry period under 40 days. In the present study it was 
found that dry periods between 60 and 70 days (which was the maximum dry period length 
observed in studied herds) increased the probability of isolation of S. non-agalactiae (p<0.05). 
Dry periods shorter than 45 days were less likely than the previous, to increase the probability 
of isolation. This finding should be cautiously regarded as a protective determinant factor, since 
the use of this dry period duration reflects the reality of only 9 farms. Furthermore, Church et al. 
(2008) and Pinedo et al. (2011) reported that no difference in somatic cell count and cases of 
mastitis were found for shorted dry periods (from 30 to 34) versus 45-, 55-, and 60-dry periods. 
In the present study, difference of duration of the dry period influenced the occurrence of  
mastitis by S. non-agalactiae, being the dry period of 45 to 60 days better to prevent infection by 
this agent. 
Possible effects of teat disinfection practices were also investigated, although the composition   
of the dipping solution was not assessed. It was observed that the simultaneous use of pre- and 
post-milking teat dipping, was associated with a higher probability of isolating Streptococcus 
non-agalactiae (p<0.05). In contrast, absence of teat disinfection in milking was associated with 
decreasing isolation probability. Such result was equally found in the analysis of the relationship 
between isolation of environmental agents and use of teat disinfections (p<0.01). Post-dipping is 
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used as a control measure of contagious mastitis for several years, whereas pre-dipping, more 
recent, is used as a control measure in the case of environmental mastitis (Morn, 2009). Teat 
dipping in solutions composed by, for instance sodium hypochlorite, iodine, chlorhexidine and 
chorine, decreases the population of microorganisms on the teat skin. At the end of milking, 
debris of dipping should be discarded and the container should be cleaned before the next 
milking to avoid contamination. In addition, components of the dipping solution may be 
inactivated with organic material and thus it is important that the dipping container does not 
become contaminated with feces (Blowery & Edmondson, 2010). The results obtained in this 
study, can be explain by bad dipping practices (can act as a source of infection if the product is 
contaminated at the time of administration when both teat disinfectants are used) or by the fact 
that dipping practices were being used in the most affected farms. 
To assess the influence of the season, the year was divided into four trimesters, starting in 
January. Significant association (p<0.05) was found between the fourth trimester and increased 
frequency of S. uberis isolates, i.e. between October and December. The first trimester of the 
year (January-March) followed. The second trimester corresponding to the spring season was 
the one where fewer S. uberis isolates were found. 
Similarly to S. uberis the frequency of isolates of Enterococcus and environmental agents, was 
significantly higher (p<0.01) in the fourth trimester (from October to December), followed by the 
first trimester (January until March). The summer season (third trimester) was the period of the 
year when the frequency of isolates of these agents was lower. 
Described results of increased frequency of isolation during the fourth and first trimester can be 
explained by the recognized effects of temperature and humidity over mastitis (Morse et al., 
1988). Indeed, the fourth and first trimester of the year correspond to the months of greater 
humidity in São Miguel. Although the rain is more or less constant throughout the year in the 
island, it is more intensive during winter, i.e. from October until March. Similarly, Lopez- 
Benavides el al. (2007) reported the lowest concentration of S. uberis in several ecological 
niches of a dairy farm of New Zealand during the summer season. 
Finally, concerning the remaining factors, namely the type of milking machine, the existence of 
cowshed and the location of farms no significant statistical association was observed. The type 
of milking machine was used as a variable in the study because a large proportion of producers 
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use mobile outdoor milking equipment’s, given that the cows are at pasture. This is different 
from the reality observed in the farms of Portugal mainland. 
The present study has some limitations, namely due to the impossibility of performing the 
questionnaires in all of the 133 holdings that provided milk samples to the AJAM laboratory 
throughout the year of 2013. It was further difficult to engage the producers to answer all of the 
parameters abridged by the questionnaire. Concerning the laboratory records, the major 
limitations were the absence of information regarding the patterns of resistance of isolated 
agents. Comparison with previous national and foreign studies was also hampered by the 
different ABs employed in the susceptibility testing assays. 
The major outcomes of this study were: 1) higher percentage of environmental agents isolated 
in the analyzed milk samples; 2) isolation of a significant number of contagious agents with a 
good AB response; 3) association of teat dipping practices and internal teat sealant to a higher 
percentage of isolation of some agents, contrarily to what might be expected. The findings of  
the present study suggest that an improvement of the holdings hygiene along with better 
compliance with good milking practices might contribute to a decrease of mastitis occurrence. 
Thus, further work is needed to characterize the features of the Azorean holdings and herds  
that can sustain the high frequency of occurrence of mastitis caused by environmental agents. It 
would also be important to determine the resistance patterns and identify the agents involved 
not only in clinical mastitis, as well as in subclinical mastitis. Other significant aspects that 
deserve further attention are determination of the risk factors for the occurrence of mastitis, 
based particularly on the characteristic management of the holdings of São Miguel, hygiene 
scores, compliance with good milking practices and the influence of different dry periods. By 
targeting these aspects, better and more effective mastitis control plans could be implemented 
with the aim to provide a higher quality and valorization of Azorean milk and its derivatives. 
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Annex 2 
  
 
 
 
Estudo retrospectivo sobre agentes de mastites e a sua 
sensibilidade a antimicrobianos em explorações de bovinos de 
leite de S. Miguel  (Açores) 
 
 
 
 
Questionário 
 
NOTAS PRÉVIAS 
 
Os dados recolhidos por este questionário destinam4se exclusivamente a fins 
académicos, especificamente no âmbito da Tese de Mestrado em Medicina Veterinária 
da aluna da Escola Universitária Vasco da Gama Andreia Filipa Gomes Vieira, sendo 
que a confidencialidade dos dados recolhidos é assegurada. 
 
Os dados são recolhidos após o consentimento expresso dos respectivos proprietários, 
previamente informados sobre a natureza e objectivos do estudo. 
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IDENTIFICAÇÃO DA EXPLORAÇÃO 
A. Nome do proprietário:    
B. Local da exploração (Concelho):    
C. Número de animais na exploração:    
D. Número de vacas em ordenha:    
 
 
 
 
 
 
CARACTERÍSTICAS DA EXPLORAÇÃO 
E. Número de vacas com mais que um parto:    
F. Tipo de exploração: 
Vacas sempre em pastoreio 
Vacas secas em pastoreio e vacas em lactação estabuladas 
Vacas sempre estabuladas 
Estabulação no Inverno 
G. Realiza a recria: 
Sim  Não 
H. Exploração: 
Aberta  Fechada 


H.1. Se ABERTA adquiriu animais: 
Nos  últimos  6  meses   
No último ano 
Há mais de um ano 
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MANEIO DAS VACAS SECAS 
I. Duração em média do período de seca: 
> que 60 dias e < que 70 dias 
> 70 dias 
> que 45 e < que 60 dias 
< 45 dias 
J. Realiza a separação de vacas secas das vacas em lactação: 
Sim  Não 
K. Utiliza antibióticos intraamamários à secagem: 
Sempre  
Frequentemente  
Raramente 
Só em caso de mamites identificadas 
Nunca 
L. Utiliza selantes internos a secagem: 
Sempre  
Frequentemente  
Raramente  
Nunca 
M. Realiza a testagem de animais a secagem: 
Sempre  
Frequentemente  
Raramente  
Nunca 

12.1 Se REALIZA testagem, qual: 
Isolamento  e  TSA   
TCM 
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N. Local do parto: 
Maternidade individual 
Parque das secas 
Parque das vacas em lactação 
Outro:    
 
 
 
 
HIGIENE NA ORDENHA 
O. Utiliza luvas durante a ordenha: 
Sim  Não 
P. Utiliza: 
Pré4dipping  
Pós4dipping  
Ambos  
Nenhum 
Q. Realiza a limpeza do úbere com toalhetes individuais secos: 
Sim  Não 
R. Desinfecção de tetinas entre ordenhas: 
Sim  Não 
S. Ordenha as vacas com problemas de mastites no fim da ordenha: 
Sim  Não 
T. Tipo de ordenha: 
Móvel  Fixa 
U. Nº de pontos de ordenha:    
 
 
 
 
MANEIO ALIMENTAR VACAS SECAS, PRODUÇÃO, NOVILHAS 
V. Utiliza correctores vitamínicos e minerais nas vacas em lactação: 
Sim  Não 
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W. E nas vacas secas: 
Sim  Não 
